GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders
Ryan Allway July 5th, 2023 News, Top News, Top Story BALTIMORE, July 05, 2023 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that it has been granted final approval for... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )